485 related articles for article (PubMed ID: 29721686)
21. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
[TBL] [Abstract][Full Text] [Related]
22. Value of discrepancy of the central scar-like structure between dynamic CT and gadoxetate disodium-enhanced MRI in differentiation of focal nodular hyperplasia and hepatocellular adenoma.
Park HJ; Byun JH; Kang JH; Kang HJ; Yu E; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
Eur J Radiol; 2021 Jun; 139():109730. PubMed ID: 33930719
[TBL] [Abstract][Full Text] [Related]
23. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study.
Nowicki TK; Markiet K; Izycka-Swieszewska E; Dziadziuszko K; Studniarek M; Szurowska E
BMC Gastroenterol; 2018 Jan; 18(1):10. PubMed ID: 29334905
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.
Agarwal S; Fuentes-Orrego JM; Arnason T; Misdraji J; Jhaveri KS; Harisinghani M; Hahn PF
AJR Am J Roentgenol; 2014 Oct; 203(4):W408-14. PubMed ID: 25055198
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Value of Gadoxetic Acid-Enhanced MR Imaging to Distinguish HCA and Its Subtype from FNH: A Systematic Review.
Guo Y; Li W; Cai W; Zhang Y; Fang Y; Hong G
Int J Med Sci; 2017; 14(7):668-674. PubMed ID: 28824299
[No Abstract] [Full Text] [Related]
26. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T
AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
[TBL] [Abstract][Full Text] [Related]
27. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience.
Grieser C; Steffen IG; Kramme IB; Bläker H; Kilic E; Perez Fernandez CM; Seehofer D; Schott E; Hamm B; Denecke T
Eur Radiol; 2014 Jun; 24(6):1339-48. PubMed ID: 24658870
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis.
Alamri TM; Cerny M; Al Shaikh M; Billiard JS; Olivié D; Chagnon M; Tang A
Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729
[TBL] [Abstract][Full Text] [Related]
29. Quantitative information from gadobenate dimeglumine-enhanced MRI can predict proliferative subtype of solitary hepatocellular carcinoma: a multicenter retrospective study.
Ding F; Huang M; Ren P; Zhang J; Lin Z; Sun Y; Liang C; Zhao X
Eur Radiol; 2024 Apr; 34(4):2445-2456. PubMed ID: 37691080
[TBL] [Abstract][Full Text] [Related]
30. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.
Grazioli L; Morana G; Kirchin MA; Caccia P; Romanini L; Bondioni MP; Procacci C; Chiesa A
J Magn Reson Imaging; 2003 May; 17(5):593-602. PubMed ID: 12720270
[TBL] [Abstract][Full Text] [Related]
31. Ascites relative enhancement during hepatobiliary phase after Gd-BOPTA administration: a new promising tool for characterising abdominal free fluid of unknown origin.
Bonatti M; Valletta R; Zamboni GA; Lombardo F; Senoner M; Simioni M; Schifferle G; Bonatti G
Eur Radiol; 2019 Jun; 29(6):2830-2836. PubMed ID: 30643946
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
Bieze M; van den Esschert JW; Nio CY; Verheij J; Reitsma JB; Terpstra V; van Gulik TM; Phoa SS
AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
[TBL] [Abstract][Full Text] [Related]
33. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis.
Grazioli L; Bondioni MP; Haradome H; Motosugi U; Tinti R; Frittoli B; Gambarini S; Donato F; Colagrande S
Radiology; 2012 Feb; 262(2):520-9. PubMed ID: 22282184
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
Auer TA; Fehrenbach U; Grieser C; Penzkofer T; Geisel D; Schmelzle M; Müller T; Bläker H; Seehofer D; Denecke T
Eur Radiol; 2020 Jun; 30(6):3497-3506. PubMed ID: 32086574
[TBL] [Abstract][Full Text] [Related]
36. The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma: a prospective study of diagnostic accuracy.
Bieze M; Bennink RJ; El-Massoudi Y; Phoa SS; Verheij J; Beuers U; van Gulik TM
Nucl Med Commun; 2013 Feb; 34(2):146-54. PubMed ID: 23154640
[TBL] [Abstract][Full Text] [Related]
37. Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns.
Denis de Senneville B; Frulio N; Laumonier H; Salut C; Lafitte L; Trillaud H
Eur Radiol; 2020 May; 30(5):2995-3003. PubMed ID: 32002637
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
[No Abstract] [Full Text] [Related]
39. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings.
Laumonier H; Cailliez H; Balabaud C; Possenti L; Zucman-Rossi J; Bioulac-Sage P; Trillaud H
AJR Am J Roentgenol; 2012 Aug; 199(2):341-8. PubMed ID: 22826395
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of texture analysis for the differential diagnosis of focal nodular hyperplasia from hepatocellular adenoma on contrast-enhanced CT images.
Cannella R; Borhani AA; Minervini MI; Tsung A; Furlan A
Abdom Radiol (NY); 2019 Apr; 44(4):1323-1330. PubMed ID: 30267107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
